Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.50 billion. The enterprise value is $1.26 billion.
| Market Cap | 1.50B |
| Enterprise Value | 1.26B |
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 131.63 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 131.63M |
| Shares Outstanding | 131.63M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | -3.96% |
| Owned by Insiders (%) | 2.22% |
| Owned by Institutions (%) | 54.59% |
| Float | 127.58M |
Valuation Ratios
The trailing PE ratio is 27.10 and the forward PE ratio is 17.71.
| PE Ratio | 27.10 |
| Forward PE | 17.71 |
| PS Ratio | 6.14 |
| Forward PS | 10.83 |
| PB Ratio | 4.52 |
| P/TBV Ratio | 4.52 |
| P/FCF Ratio | 16.19 |
| P/OCF Ratio | 16.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.30, with an EV/FCF ratio of 13.67.
| EV / Earnings | 20.84 |
| EV / Sales | 4.86 |
| EV / EBITDA | 15.30 |
| EV / EBIT | 20.02 |
| EV / FCF | 13.67 |
Financial Position
The company has a current ratio of 5.23, with a Debt / Equity ratio of 0.24.
| Current Ratio | 5.23 |
| Quick Ratio | 4.54 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.98 |
| Debt / FCF | 0.89 |
| Interest Coverage | 13.91 |
Financial Efficiency
Return on equity (ROE) is 17.33% and return on invested capital (ROIC) is 9.09%.
| Return on Equity (ROE) | 17.33% |
| Return on Assets (ROA) | 7.69% |
| Return on Invested Capital (ROIC) | 9.09% |
| Return on Capital Employed (ROCE) | 14.87% |
| Revenue Per Employee | $2.00M |
| Profits Per Employee | $466,431 |
| Employee Count | 130 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, AUPH has paid $1.85 million in taxes.
| Income Tax | 1.85M |
| Effective Tax Rate | 2.96% |
Stock Price Statistics
The stock price has increased by +110.19% in the last 52 weeks. The beta is 1.24, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +110.19% |
| 50-Day Moving Average | 8.85 |
| 200-Day Moving Average | 8.36 |
| Relative Strength Index (RSI) | 73.80 |
| Average Volume (20 Days) | 2,577,175 |
Short Selling Information
The latest short interest is 10.63 million, so 8.07% of the outstanding shares have been sold short.
| Short Interest | 10.63M |
| Short Previous Month | 10.02M |
| Short % of Shares Out | 8.07% |
| Short % of Float | 8.33% |
| Short Ratio (days to cover) | 5.10 |
Income Statement
In the last 12 months, AUPH had revenue of $260.11 million and earned $60.64 million in profits. Earnings per share was $0.42.
| Revenue | 260.11M |
| Gross Profit | 208.51M |
| Operating Income | 63.11M |
| Pretax Income | -48.10M |
| Net Income | 60.64M |
| EBITDA | 82.58M |
| EBIT | 63.11M |
| Earnings Per Share (EPS) | $0.42 |
Balance Sheet
The company has $315.05 million in cash and $81.83 million in debt, giving a net cash position of $233.22 million or $1.77 per share.
| Cash & Cash Equivalents | 315.05M |
| Total Debt | 81.83M |
| Net Cash | 233.22M |
| Net Cash Per Share | $1.77 |
| Equity (Book Value) | 335.30M |
| Book Value Per Share | 2.53 |
| Working Capital | 330.70M |
Cash Flow
In the last 12 months, operating cash flow was $92.68 million and capital expenditures -$256,000, giving a free cash flow of $92.43 million.
| Operating Cash Flow | 92.68M |
| Capital Expenditures | -256,000 |
| Free Cash Flow | 92.43M |
| FCF Per Share | $0.70 |
Margins
Gross margin is 80.16%, with operating and profit margins of 24.26% and 23.31%.
| Gross Margin | 80.16% |
| Operating Margin | 24.26% |
| Pretax Margin | 24.02% |
| Profit Margin | 23.31% |
| EBITDA Margin | 31.75% |
| EBIT Margin | 24.26% |
| FCF Margin | 35.53% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
| Earnings Yield | 4.05% |
| FCF Yield | 6.18% |
Analyst Forecast
The average price target for AUPH is $12.25, which is 7.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.25 |
| Price Target Difference | 7.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 12.52% |
| EPS Growth Forecast (5Y) | 101.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 3.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | 6 |